The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.

Guam EPA’s Beach Watch Program issued a beach advisory that includes all 43 beaches due to the large amount of rain received ...

The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...

The FDA has approved Linzess (linaclotide) for children aged 7 and older with IBS-C, marking the first FDA-approved drug for ...

A Listeria outbreak has claimed the lives of at least six people and hospitalized dozens more, including two in Louisiana.

The family of two-year-old De'Markus Jeremiah Page has filed a lawsuit against Shands Children's Hospital after his death, ...

The Philippine Health Insurance Corp. now covers 343 medical services provided in emergency rooms under the PhilHealth ...

Health experts call for stronger regulation and enforcement as recent deaths linked to contaminated cough syrup reignite ...

We chatted with experts about how to keep pets safe and healthy during the holidays. Here are their tips for pet-proofing ...